Inhibition by somatostatin of insulin release from isolated pancreatic islets [PDF]
Hiroshi Okamoto+4 more
openalex +1 more source
Characterisation of sleep apneas and respiratory circuitry in mice lacking CDKL5
Summary CDKL5 deficiency disorder is a rare genetic disease caused by mutations in the CDKL5 gene. Central apneas during wakefulness have been reported in patients with CDKL5 deficiency disorder. Studies on CDKL5‐knockout mice, a CDKL5 deficiency disorder model, reported sleep apneas, but it is still unclear whether these events are central (central ...
Gabriele Matteoli+12 more
wiley +1 more source
Vasoactive intestinal peptide stimulates pancreatic somatostatin release [PDF]
Eli Ipp, Richard Dobbs, Roger H. Unger
openalex +1 more source
Somatostatin-expressing neurons in cortical networks
J. Urban-Ciecko, Alison L. Barth
semanticscholar +1 more source
MRI‐based surrogates of brain clearance in narcolepsy type 1
Summary Brain clearance involves the drainage of waste molecules from the brain, a process that is suggested to be amplified during sleep. Recently proposed MRI‐based methods attempt to approximate human brain clearance with surrogate measures. The current study aimed to explore whether two brain clearance surrogates are altered in narcolepsy.
Eva M. van Heese+6 more
wiley +1 more source
Somatostatin inhibition of rat growth hormone release in vitro in the presence of BaCl2 or 3‐isobutyl‐1‐methylxanthine [PDF]
Joe Schofield+3 more
openalex +1 more source
Somatostatin Receptor Antagonists for Imaging and Therapy
M. Fani, G. Nicolas, D. Wild
semanticscholar +1 more source
The Space–Time Organisation of Sleep Slow Oscillations as Potential Biomarker for Hypersomnolence
ABSTRACT Research suggests that the spatial profile of slow wave activity (SWA) could be altered in hypersomnolence. Slow oscillations (SOs; 0.5–1.5 Hz), single waveform events contributing to SWA, can be labelled as Global, Frontal, or Local depending on their presentation on the scalp.
Mahmoud Alipour+5 more
wiley +1 more source
Abstract figure legend Somatostatin binds to a G‐protein‐coupled receptor to inhibit the release of catecholamine from chromaffin cells. This action has no impact on Ca2+ levels and is similar for Ca2+ entry through voltage‐gated Ca2 channels and for Ca2+ mobilization from the endoplasmic reticulum.
Jinbo Cheng, Meyer B. Jackson
wiley +1 more source
EFFECTS OF SOMATOSTATIN ON PLASMA INSULIN, GROWTH HORMONE AND GLUCAGON LEVELS IN OBESE AND DIABETIC CHILDREN AND ADOLESCENTS [PDF]
L Gargantini, G Chiumello
openalex +1 more source